This panel at the 44th J.P. Morgan Healthcare Conference will explore biological risks faced by the healthcare industry, including climate-driven diseases and engineered pathogens. Experts will discuss vulnerabilities and strategies for building resilience and cross-border cooperation to protect public health and markets. Open to all conference attendees.